FierceBiotech

Vertex Pharmaceuticals Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Subordinated Notes

CAMBRIDGE, Mass., Feb 11, 2008 -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it intends to offer, subject to market and other conditions, 6,000,000 shares of its common ...
The Motley Fool

Vertex Pharmaceuticals May Be About to Solve a Common Health Problem. Is the Stock a Buy?

Vertex's cystic fibrosis portfolio has been a raging success for the company. The biotech’s next potential product addresses the extremely common problem of pain -- and could become its next ...
FierceBiotech

Vertex Pharmaceuticals Announces Pricing of Public Offering of Common Stock

- 11.5 million shares of common stock at $38.50 per share for gross proceeds of $442.8 million - CAMBRIDGE, Mass., Dec 02, 2009 (BUSINESS WIRE) -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) ...
The Motley Fool

This Program for a Common Problem May Be Vertex Pharmaceuticals' Ticket to a New Wave of Billion-Dollar Revenues

Vertex Pharmaceuticals is the global leader in cystic fibrosis treatment, and that business generates billions of dollars in annual revenue. The biotech has treatment candidate in another indication ...
Investing

Vertex trust sells over $1.46 million in class A common stock

In recent trading activity, the 2020 Irrevocable Trust for the Benefit of Nicholas A. Shuhan, a significant shareholder in Vertex (NASDAQ:VRTX), Inc. (NASDAQ:VERX), has sold a substantial number of ...
Seeking Alpha

Vertex launches late-stage study of triplet CF therapy in patients with most common mutations

Vertex Pharmaceuticals (NASDAQ:VRTX) initiates a Phase 3 clinical trial assessing a fixed-dose combination of VX-659 (240 mg), tezacaftor (100 mg) and ivacaftor (150 mg) in cystic fibrosis (CF) ...
Investing

Vertex trust sells over $1.46 million in class A common stock

This significant sell-off resulted in the trust's holdings in Vertex decreasing to 128,983.294 shares of Class A Common Stock. This move by the trust has caught the attention of investors, as it ...